Clinical trial
Differences in Lipid and Cognitive Change Between One-month and 3-month Paliperidone Palmitate Treatment in Stable Schizophrenia
NCT04754750 is registered in ClinicalTrials.gov with Calo Psychiatric Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differences in Lipid and Cognitive Change Between One-month and 3-month Paliperidone Palmitate Treatment in Stable Schizophrenia
- Lead sponsor
- Calo Psychiatric Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2015
- Completion date
- June 30, 2017
- Enrollment
- 72 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenics